| Penny J Ogden, CRNA | |
|
950 Medical Dr, Brigham City, UT 84302-4724 | |
| (800) 594-6399 | |
| (801) 733-5618 |
| Full Name | Penny J Ogden |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 950 Medical Dr, Brigham City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265453088 | NPI | - | NPPES |
| 87040324684121 A004 | Other | UT | TRICARE |
| PRA04451 | Other | UT | MOLINA |
| 2080245 | Other | UT | UHC |
| 107001918101 | Other | UT | IHC |
| QM0000076538 | Other | UT | ALTIUS |
| 340896 | Other | UT | DMBA |
| 870576522OG1 | Other | UT | EDUCATOR'S |
| 47568 | Other | UT | PEHP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 225108-4406 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Penny J Ogden, CRNA 1954 Fort Union Blvd, Salt Lake City, UT 84121-6800 Ph: (801) 993-9500 | Penny J Ogden, CRNA 950 Medical Dr, Brigham City, UT 84302-4724 Ph: (800) 594-6399 |
News Archive
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
A new study that recently appeared on the preprint server medRxiv* makes use of a combined method to estimate population exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), taking into account the fact that patients who recover from the infection often do not have circulating antibodies against the virus.
University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination - including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.
Estrogen therapy can help keep joint pain at bay after menopause for women who have had a hysterectomy. Joint pain was modestly, but significantly, lower in women who took estrogen alone than in women who took placebo in the Women's Health Initiative (WHI) trial.
› Verified 9 days ago
Mr. Derek C Lish, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 950 Medical Dr, Brigham City, UT 84302 Phone: 435-734-9471 | |
Mr. Scott Christian Phillips, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 950 S 500 W, Brigham City, UT 84302 Phone: 435-734-9471 |